ArticleInternational immunopharmacology2022

Immunoglobulin yolk targeting spike 1, receptor binding domain of spike glycoprotein and nucleocapsid of SARS-CoV-2 blocking RBD-ACE2 binding interaction.

Meliana Eka Saputri et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.